DAPK1 and colorectal carcinoma: Other researchers described missense, amplification and deep detection mutations in twenty genes, among them five ATG genes (e.g., DAPK1, ULK1, PELP1, TSC1 and CASP3) that have a mutation rate ≥ 3 and are associated with OS in CRC patients.